COVID-19 PPE joint venture
Company: CleanSpark
The claim, verbatim
Entered into joint venture with international partners to procure, distribute and supply masks, gowns, gloves and other PPE to hospitals and frontline medical personnel, with Company receiving $0.20 per unit sold and ability to reinvest capital for follow-on purchases
Source (primary)
CleanSpark 10-Q filed 2020-05-11 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “CleanSpark entered into a joint venture agreement with international partners to procure, distribute and supply masks, gowns, gloves, and other Personal Protective Equipment (PPE) to be supplied to hospitals and frontline medical personnel. In connection with its contribution of capital, the Company will receive $0.20 per unit sold through use of its funds, with the ability to re-invest the contributed capital for follow-on purchases at least four (4) times over”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms CleanSpark 10-Q filed 2020-05-11
Quote: “CleanSpark entered into a joint venture agreement with international partners to procure, distribute and supply masks, gowns, gloves, and other Personal Protective Equipment (PPE) to be supplied to hospitals and frontline medical personnel. In connection with its contribution of capital, the Company will receive $0.20 per unit sold through use of its funds, with the ability to re-invest the contributed capital for follow-on purchases at least four (4) times over”